| pubmed-article:12945594 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12945594 | lifeskim:mentions | umls-concept:C0205282 | lld:lifeskim |
| pubmed-article:12945594 | lifeskim:mentions | umls-concept:C0149744 | lld:lifeskim |
| pubmed-article:12945594 | lifeskim:mentions | umls-concept:C0456389 | lld:lifeskim |
| pubmed-article:12945594 | lifeskim:mentions | umls-concept:C0028415 | lld:lifeskim |
| pubmed-article:12945594 | lifeskim:mentions | umls-concept:C0439792 | lld:lifeskim |
| pubmed-article:12945594 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:12945594 | pubmed:dateCreated | 2003-8-29 | lld:pubmed |
| pubmed-article:12945594 | pubmed:abstractText | We examined clinical parameters of patients from Northern Ireland with potentially malignant lesions (PML) to determine association with development of intraoral squamous cell carcinoma (SCC). | lld:pubmed |
| pubmed-article:12945594 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12945594 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12945594 | pubmed:citationSubset | D | lld:pubmed |
| pubmed-article:12945594 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12945594 | pubmed:month | May | lld:pubmed |
| pubmed-article:12945594 | pubmed:issn | 1354-523X | lld:pubmed |
| pubmed-article:12945594 | pubmed:author | pubmed-author:StevensonMM | lld:pubmed |
| pubmed-article:12945594 | pubmed:author | pubmed-author:TonerP GPG | lld:pubmed |
| pubmed-article:12945594 | pubmed:author | pubmed-author:CowanC GCG | lld:pubmed |
| pubmed-article:12945594 | pubmed:author | pubmed-author:GreggT ATA | lld:pubmed |
| pubmed-article:12945594 | pubmed:author | pubmed-author:MEHTAKK | lld:pubmed |
| pubmed-article:12945594 | pubmed:author | pubmed-author:NapierS SSS | lld:pubmed |
| pubmed-article:12945594 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12945594 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:12945594 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12945594 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12945594 | pubmed:pagination | 129-37 | lld:pubmed |
| pubmed-article:12945594 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:meshHeading | pubmed-meshheading:12945594... | lld:pubmed |
| pubmed-article:12945594 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12945594 | pubmed:articleTitle | Potentially malignant oral lesions in Northern Ireland: size (extent) matters. | lld:pubmed |
| pubmed-article:12945594 | pubmed:affiliation | Department of Histopathology, Royal Group of Hospitals Trust, Belfast, UK. seamus.napier@bll.n-i.nhs.uk | lld:pubmed |
| pubmed-article:12945594 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12945594 | pubmed:publicationType | Comparative Study | lld:pubmed |
